Growth Metrics

Bio-Techne (TECH) Other financing activities (2009 - 2022)

Bio-Techne's quarterly Other financing activities came in at -$2.5 million in Q3 2022, down 113.43% year-on-year from $18.3 million in Q3 2021, and down 172.26% quarter-over-quarter from $3.4 million in Q1 2022.

Bio-Techne has reported Other financing activities for 14 years, with the latest figure at -$2.5 million in Q3 2022.

  • For the quarter ending Q3 2022, Other financing activities fell 113.43% year-over-year to -$2.5 million; the trailing twelve-month figure through Jun 2023 stood at -$2.5 million (down 108.84% YoY), and the FY2023 full-year result was -$2.5 million, down 411.8% from the prior year.
  • Other financing activities for Q3 2022 stood at -$2.5 million, down from $3.4 million in the prior quarter.
  • The five-year high for Other financing activities was $41.6 million in Q2 2021, with the low at -$11.1 million in Q2 2019.
  • Average Other financing activities over 5 years is $5.3 million, with a median of $3.4 million recorded in 2018.
  • Peak annual rise in Other financing activities reached 1133.33% in 2019, while the deepest fall reached 3234.75% in 2019.
  • Tracing TECH's Other financing activities over 5 years: stood at $300000.0 in 2018, then soared by 1133.33% to $3.7 million in 2019, then gained by 29.73% to $4.8 million in 2020, then climbed by 27.08% to $6.1 million in 2021, then slumped by 140.28% to -$2.5 million in 2022.
  • The last three Other financing activities figures came in at -$2.5 million (Q3 2022), $3.4 million (Q1 2022), and $6.1 million (Q4 2021), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Bio-Techne 7.92 Bn 7.71 Bn 208.29 Mn

Historic Data

Download Data 🔒
DateValue
Sep 30, 2022 -2.46 Mn
Sep 30, 2022 -2.46 Mn
Mar 31, 2022 3.40 Mn
Mar 31, 2022 3.40 Mn
Dec 31, 2021 6.10 Mn
Dec 31, 2021 6.10 Mn
Sep 30, 2021 18.30 Mn
Sep 30, 2021 18.30 Mn
Jun 30, 2021 41.60 Mn
Jun 30, 2021 41.60 Mn
Mar 31, 2021 11.70 Mn
Mar 31, 2021 11.70 Mn
Dec 31, 2020 4.80 Mn
Dec 31, 2020 4.80 Mn
Sep 30, 2020 3.30 Mn
Sep 30, 2020 3.30 Mn
Jun 30, 2020 9.20 Mn
Jun 30, 2020 9.20 Mn
Mar 31, 2020 1.50 Mn
Mar 31, 2020 1.50 Mn
Dec 31, 2019 3.70 Mn
Dec 31, 2019 3.70 Mn
Sep 30, 2019 3.20 Mn
Sep 30, 2019 3.20 Mn
Jun 30, 2019 -11.10 Mn
Jun 30, 2019 -11.10 Mn
Mar 31, 2019 1.10 Mn
Mar 31, 2019 1.10 Mn
Dec 31, 2018 300,000.00
Dec 31, 2018 300,000.00
Sep 30, 2018 3.40 Mn
Sep 30, 2018 3.40 Mn
Jun 30, 2018 354,000.00
Jun 30, 2018 354,000.00
Mar 31, 2018 -2.18 Mn
Mar 31, 2018 -2.18 Mn
Dec 31, 2017 -355,000.00
Dec 31, 2017 -355,000.00
Sep 30, 2017 -1.80 Mn
Sep 30, 2017 -1.80 Mn
Jun 30, 2017 771,000.00
Jun 30, 2017 771,000.00
Mar 31, 2017 -86,000.00
Mar 31, 2017 -86,000.00
Dec 31, 2016 82,000.00
Dec 31, 2016 82,000.00
Sep 30, 2016 -253,000.00
Sep 30, 2016 -253,000.00
Jun 30, 2016 -327,000.00
Jun 30, 2016 -327,000.00
Mar 31, 2016 -119,000.00
Mar 31, 2016 -119,000.00
Dec 31, 2015 11,000.00
Dec 31, 2015 11,000.00
Sep 30, 2015 -131,000.00
Sep 30, 2015 -131,000.00
Jun 30, 2015 -1.01 Mn
Jun 30, 2015 -1.01 Mn
Mar 31, 2015 134,000.00
Mar 31, 2015 134,000.00
Dec 31, 2014 180,000.00
Dec 31, 2014 180,000.00
Sep 30, 2014 78,000.00
Sep 30, 2014 78,000.00
Jun 30, 2014 262,000.00
Jun 30, 2014 262,000.00
Mar 31, 2014 -40,000.00
Mar 31, 2014 -40,000.00
Dec 31, 2013 36,000.00
Dec 31, 2013 36,000.00
Sep 30, 2013 4,000.00
Sep 30, 2013 4,000.00
Jun 30, 2013 6,000.00
Jun 30, 2013 6,000.00
Mar 31, 2013 5,000.00
Mar 31, 2013 5,000.00
Dec 31, 2012 63,000.00
Dec 31, 2012 63,000.00
Sep 30, 2012 1,000.00
Sep 30, 2012 1,000.00
Mar 31, 2012 38,000.00
Mar 31, 2012 38,000.00
Dec 31, 2011 6,000.00
Dec 31, 2011 6,000.00
Sep 30, 2011 7,000.00
Sep 30, 2011 7,000.00
Jun 30, 2011 428,000.00
Jun 30, 2011 428,000.00
Mar 31, 2011 6,000.00
Mar 31, 2011 6,000.00
Dec 31, 2010 330,000.00
Dec 31, 2010 330,000.00
Sep 30, 2010 83,000.00
Sep 30, 2010 83,000.00
Jun 30, 2010 19,000.00
Jun 30, 2010 19,000.00
Mar 31, 2010 126,000.00
Mar 31, 2010 126,000.00
Dec 31, 2009 41,000.00
Dec 31, 2009 41,000.00
Sep 30, 2009 10,000.00
Sep 30, 2009 10,000.00